EUVIMEDEUVIMED entdecken
Crossref

The effect of levodopa on the blood antioxidant system and metabolome in patients with Parkinson's disease

D A Abaimov, T N Fedorova, A A Shabalina, A S Silantyev, D N Konanov, E Yu Fedotova, V V Poleshchuk, M N Andreev, O V Trifonova, D L Maslov, E E Balashova, D A Sychev und 2 weitere

Biomeditsinskaya Khimiya · 2026-05 · 72 (2) · 141-151

DOI: 10.18097/pbmcr1642 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomeditsinskaya Khimiya, 2026. Verfasst von D A Abaimov und 13 weiteren Autor:innen. Beteiligte Einrichtung: Russian Center for Neurology and Neurosciences, Moscow, Russia. Hauptthemen laut MEDLINE: Levodopa, Parkinson Disease, Metabolome, Antioxidants. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The blood serum antioxidant status and the blood plasma metabolomic profile have been analyzed in Parkinson's disease (PD) patients, both pharmacologically naive and taking levodopa (treatment duration 7.4±5.4 years) at low (< 300 mg/day) and high (> 300 mg/day) doses. High-dose levodopa therapy caused changes in both the antioxidant status and metabolome of patients. High-dose levodopa treatment also activated lipid peroxidation, manifested by an increase in the level of lipid hydroperoxides. High-resolution mass spectrometry revealed accumulation of levodopa and dopamine metabolic products in the metabolome, particularly the neurotoxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL), and associated changes in related metabolic pathways. Low-dose levodopa treatment did not cause significant changes in the antioxidant status and metabolome of patients, thus suggesting that maintaining a low-dose regimen as long as possible could potentially reduce neurotoxic metabolite accumulation and also maintain normal antioxidant functions in PD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevodopaParkinson DiseaseMetabolomeAntioxidantsAntiparkinson AgentsHumansMaleFemaleAgedLipid PeroxidationMiddle Aged3,4-Dihydroxyphenylacetic Acid

Stichwörter der Autor:innen

Parkinson`s diseasedopaminelevodopamass spectrometrymetabolomepharmacometabolomics

Substanzen

LevodopaAntioxidantsAntiparkinson Agents3,4-Dihydroxyphenylacetic Acid3,4-dihydroxyphenylacetaldehyde

Autor:innen und Institutionen

  • Russian Center for Neurology and Neurosciences, Moscow, Russia.
  • Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russia.
  • Scientific Research Institute of Systems Biology and Medicine, Moscow, Russia.
  • Institute of Biomedical Chemistry, Moscow, Russia.
  • The World-class Center for Genomic Research "Center for Predictive Genetics, Pharmacogenetics and Personalized Therapy" of the Academician B.V. Petrovsky, Russian Scientific Center of Surgery, Moscow, Russia; Russian Me…

Zitieren

APA

Abaimov, D. A., Fedorova, T. N., Shabalina, A. A., Silantyev, A. S., Konanov, D. N., Fedotova, E. Y., Poleshchuk, V. V., Andreev, M. N., Trifonova, O. V., Maslov, D. L., Balashova, E. E., Sychev, D. A., Illarioshkin, S. N., & Lokhov, P. G. (2026). The effect of levodopa on the blood antioxidant system and metabolome in patients with Parkinson's disease. Biomeditsinskaya Khimiya, 72(2), 141-151. https://doi.org/10.18097/pbmcr1642

Vancouver

Abaimov DA, Fedorova TN, Shabalina AA, Silantyev AS, Konanov DN, Fedotova EY, et al. The effect of levodopa on the blood antioxidant system and metabolome in patients with Parkinson's disease. Biomeditsinskaya Khimiya. 2026;72(2):141-151. doi:10.18097/pbmcr1642

BibTeX
@article{Abaimov2026,
  author = {Abaimov, D A and Fedorova, T N and Shabalina, A A and Silantyev, A S and Konanov, D N and Fedotova, E Yu and Poleshchuk, V V and Andreev, M N and Trifonova, O V and Maslov, D L and Balashova, E E and Sychev, D A and Illarioshkin, S N and Lokhov, P G},
  title = {The effect of levodopa on the blood antioxidant system and metabolome in patients with Parkinson's disease},
  journal = {Biomeditsinskaya Khimiya},
  year = {2026},
  volume = {72},
  number = {2},
  pages = {141--151},
  doi = {10.18097/pbmcr1642}
}
Kostenlos starten →